Centralnic Group PLC Q&A: Interim Results for 30th June 2017 (LON:CNIC)
12 September 2017
Vir Biotechnology, Inc. (VIR) stands at a pivotal moment in its growth trajectory, presenting a remarkable investment opportunity for those interested in the healthcare sector, particularly..
CeriBell, Inc. (NASDAQ: CBLL), a rising star in the healthcare sector, is capturing the attention of investors with its innovative medical device solutions and a substantial..
Bicycle Therapeutics plc (NASDAQ: BCYC), a pioneering biotechnology firm headquartered in Cambridge, UK, is drawing significant attention from the investment community. Operating within the healthcare sector,..
Evolus, Inc. (NASDAQ: EOLS), a dynamic player in the healthcare sector, is capturing investor interest with a compelling narrative of growth potential. Specializing in the performance..
Immunome, Inc. (NASDAQ: IMNM) stands out in the biotechnology sector with its bold strides in oncology therapeutics, particularly in antibody-drug conjugates. Despite a 0.05% dip in..
Delcath Systems, Inc. (NASDAQ: DCTH) is catching the eye of investors with its significant potential upside of 89.80%, as reflected in recent analyst ratings. With a..
Relay Therapeutics, Inc. (NASDAQ: RLAY) stands out in the biotechnology sector with promising growth potential, despite the challenges highlighted by its recent financial performance. As a..
Talkspace, Inc. (TALK), a leader in virtual behavioral healthcare, is gaining attention from investors as it positions itself within the rapidly growing telehealth sector. With a..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is steadily capturing the attention of investors with its focused approach in the healthcare sector, specifically targeting the niche market of..
Valneva SE (NASDAQ: VALN), a French biotechnology company specializing in the development of vaccines for infectious diseases, presents a compelling opportunity for investors with its robust..
Geron Corporation (NASDAQ: GERN) is capturing investor attention with its promising potential upside of 173.97%, as highlighted by recent analyst ratings. This commercial-stage biopharmaceutical company, headquartered..
Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, is drawing significant attention from investors with an impressive potential upside of 93.91%, according to recent analyst..
Investors with a keen interest in the healthcare sector, particularly in medical devices, may find InMode Ltd. (NASDAQ: INMD) an intriguing prospect. Headquartered in Yokne’am, Israel,..
Sionna Therapeutics, Inc. (SION), a clinical-stage biopharmaceutical company, is capturing investor attention with its ambitious pipeline focused on treating cystic fibrosis (CF). As a trailblazer in..
ArriVent BioPharma, Inc. (NASDAQ: AVBP), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising pipeline and significant upside potential. Specializing in the..
Beta Bionics, Inc. (NASDAQ: BBNX) is capturing the attention of investors with its innovative approach in the healthcare sector, specifically within the medical devices industry. The..
Immatics N.V. (NASDAQ: IMTX), a promising player in the biotechnology sector, is capturing investor attention with its cutting-edge approach to cancer treatment. Headquartered in Tübingen, Germany,..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a promising player in the biotechnology sector, leveraging cutting-edge genetic therapies aimed at treating rare and devastating diseases. With a..
HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the health information services industry, presents an intriguing opportunity for investors looking for growth in the healthcare sector...
Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector specializing in diagnostics and research, offers a mixed bag of opportunities and challenges for..
